Are direct acting oral anticoagulants ready for prime-time use in cancer-related thrombosis?
Streiff, M.B.
Clinical Advances in Hematology and Oncology H&o 16(3): 180-184
2018
ISSN/ISBN: 1543-0790 PMID: 29742073 Document Number: 695217
Document emailed within 1 workday
Related Documents
Stebler-Fontaine, L.; Rossel, A.; Marti, C.; Righini, M.; Robert-Ebadi, H. 2019: Direct oral anticoagulants in the treatment of cancer-associated thrombosis Revue Medicale Suisse 15(674): 2232-2235Rodrigues, G. 2012: Is intensity-modulated radiotherapy for prostate cancer ready for prime-time? Canadian Journal of Urology 19(4): 6381-6382
Victora, C.G.; Barros, F.C. 2013: Participatory women's groups: ready for prime time? Lancet 381(9879): 1693-1694
Barry, D.; Keough, C.L. 2005: Ready for prime time? make your financial assistance policy a class act Healthcare Financial Management: Journal of the Healthcare Financial Management Association 59(3): 48-55
Fink, J.B. 2006: High impact aerosol technology offers higher efficiency, but is not ready for prime time Respiratory Care 51(11): 1228-1229
Kazandjian, D.; Landgren, O. 2019: Delaying the use of high-dose melphalan with stem cell rescue in multiple myeloma is ready for prime time Clinical Advances in Hematology and Oncology: H&o 17(10): 559-568
Le Mao, R.ël.; Tromeur, C.éc.; Fofana, A.; Leroyer, C.; Lacut, K. 2018: Direct oral anticoagulants La Revue du Praticien 68(5): 475-482
Lehto, M.; Mustonen, P.; Tierala, I. 2014: The use of direct oral anticoagulants (DOAC) in the treatment atrial fibrillation (AF) patients Duodecim; Laaketieteellinen Aikakauskirja 130(17): 1709-1717
Alonso Martínez, J.L.; Abínzano Guillén, M.L.; Urbieta Echezarreta, M.A.; Annichérico Sánchez, F.J.; Fernández Ladrón, V.; García Sanchotena, J.L. 2008: Low-molecular-weight heparin without oral anticoagulants for the treatment of deep vein thrombosis Anales de Medicina Interna 25(1): 4-8
Gianetti, J.; Gensini, G.; De Caterina, R. 1998: A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants Thrombosis and Haemostasis 80(6): 887-893
Roffey, P.; Thangathurai, D. 2011: Ethical issues related to direct nursing care time, compared to time spent charting in intensive care units Journal of Clinical Ethics 22(1): 94
Parakh, R.; Krishna, P.Rama.; Amin, P.; Bedi, V.S.; Desai, S.; Dumra, H.Singh.; Gupta, P.C.; Gupta, V.; Hydrabadi, R.; Kamerkar, D.; Mahajan, N.; Pai, P.; Patel, P.; Rai, K.; Sekhar, R.; Selvaraj, D.; Sharma, A.; Subrammaniyan, S.R. 2016: Consensus on Management of Deep Vein Thrombosis with Emphasis on NOACs (Non-Vitamin K Antagonist Oral Anticoagulants): Recommendations from Inter-Disciplinary Group of Indian Experts Journal of the Association of Physicians of India 64(9 Suppl): 7-26
Cosmi, B.; Palareti, G.; Moia, M.; Pengo, V.; Testa, S. 1999: Home use of an ambulatory monitor for the determination of prothrombin time (coaguchek) in patients treated with oral anticoagulants. Multicenter prospective study Minerva Cardioangiologica 47(12): 598-599
Ruparelia, N.; Panoulas, V.F.; Frame, A.; Sutaria, N.; Ariff, B.; Gopalan, D.; Chukwuemeka, A.; Mikhail, G.W.; Malik, I.S. 2016: Successful Treatment of very Early Thrombosis of SAPIEN 3 Valve with Direct Oral Anticoagulant Therapy Journal of Heart Valve Disease 25(2): 211-213
Tripodi, A.; Chantarangkul, V.; Clerici, M.; Mannucci, P.M. 2002: Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA Thrombosis and Haemostasis 88(4): 583-586
Lavrinovich, T.S.; Amelin, A.Z.; Dombrovska, L.E.; Liepa, M.E. 1978: Effect of indirectly acting anticoagulants on experimental posttraumatic pulmonary fat embolism Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 6: 33-36
Mystakidou, K.; Katsouda, E.; Tsilika, E.; Smyrniotis, V.; Vassiliou, I.; Tsiatas, M.; Vlahos, L. 2006: Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment Anticancer Research 26(3b): 2325-2328
Grauerholz, E.; King, A. 1997: Prime time sexual harassment Violence Against Women 3(2): 129-148
Wharton, H.C. 2012: A 21-year-old white woman diagnosed with cerebral venous sinus thrombosis related to oral contraceptive and Factor V Leiden Advanced Emergency Nursing Journal 34(1): 10-15
Bowers, L.A. 2010: Prime time to increase efficiency through operations Medical Economics 87(17): 28-30